Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 6/20 | 0.38 |
| ▸ | PSEN1 | P49768 | 7/20 | 0.37 |
| ▸ | PSEN2 | P49810 | 7/20 | 0.37 |
| ▸ | APH1B | Q8WW43 | 7/20 | 0.37 |
| ▸ | NCSTN | Q92542 | 7/20 | 0.37 |
| ▸ | APH1A | Q96BI3 | 7/20 | 0.37 |
| ▸ | PSENEN | Q9NZ42 | 7/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21735508 | 0.82 | MTNR1A (0.38) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL22630110 | 0.73 | MTNR1A (0.44) | CNR2MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL21735854 | 0.72 | MTNR1A (0.42) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL21735345 | 0.71 | THRB (0.39) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL21735544 | 0.70 | MTNR1A (0.41) | CNR2MTNR1AMTNR1BALDH1A1KDM4E | |
| SCHEMBL26291799 | 0.69 | ALDH1A1 (0.43) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL23893484 | 0.69 | ALDH1A1 (0.43) | CNR2NR1H2MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL21735507 | 0.69 | NR1H2 (0.41) | NR1H2ALDH1A1KDM4E | |
| SCHEMBL21735568 | 0.69 | MTNR1A (0.42) | CNR2NR1H2MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL26291794 | 0.68 | ALDH1A1 (0.42) | CNR2NR1H2MTNR1AMTNR1BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11014901-B2 | Hydrophobic compounds for optically active devices | MERCK PATENT GMBH (DE) | 2021-05-25 | — | — | US | disclosed |
| US-20200055833-A1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200055833-A1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | UACA, CRYZ, TRPA1 | CNR2 1870/4885PSEN1 1388/4885PSEN2 1613/4885 |
| US-11014901-B2 | Hydrophobic compounds for optically active devices | UACA, CRYZ, TRPA1 | CNR2 1870/4885PSEN1 1388/4885PSEN2 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.